Evidence map›Paper›PMID 30337259›Full record

ArticleThe Lancet. Infectious diseases2018

Outbreak of Neisseria meningitidis serogroup C outside the meningitis belt-Liberia, 2017: an epidemiological and laboratory investigation.

Catherine H Bozio, Jeni Vuong, E Kainne Dokubo, Mosoka P Fallah, Lucy A McNamara, Caelin C Potts, John Doedeh, Miatta Gbanya, Adam C Retchless, Jaymin C Patel and 17 more

Abstract read
In one paragraph

Article in The Lancet. Infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors.

Catherine H BozioDivision of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Jeni VuongDivision of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
E Kainne DokuboDivision of Global Health Protection, Center for Global Health, US Centers for Disease Control and Prevention, Monrovia, Liberia.
Mosoka P FallahNational Public Health Institute of Liberia, Monrovia, Liberia.
Lucy A McNamaraDivision of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Caelin C PottsDivision of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
John DoedehLiberia Ministry of Health, Monrovia, Liberia.
Miatta GbanyaLiberia Ministry of Health, Monrovia, Liberia.
Adam C RetchlessDivision of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Jaymin C PatelDivision of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Thomas A ClarkDivision of Reproductive Health, National Center for Chronic Diseases Prevention and Health Promotion, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Henry KoharNational Public Health Institute of Liberia, Monrovia, Liberia.
Thomas NagbeNational Public Health Institute of Liberia, Monrovia, Liberia.
Peter ClementWorld Health Organization-Liberia, Monrovia, Liberia.
Victoria KataweraWorld Health Organization-Liberia, Monrovia, Liberia.
Nuha MahmoudWorld Health Organization-Liberia, Monrovia, Liberia.
Harouna M DjingareyWorld Health Organization-AFRO, Brazzaville, Republic of Congo.
Anne PerrocheauWorld Health Organization, Geneva, Switzerland.
Dhamari NaidooWorld Health Organization, Geneva, Switzerland.
Mardia StoneWorld Health Organization-Liberia, Monrovia, Liberia.
Roseline N GeorgeNational Public Health Institute of Liberia, Monrovia, Liberia.
Desmond WilliamsDivision of Global Health Protection, Center for Global Health, US Centers for Disease Control and Prevention, Monrovia, Liberia.
Alex GasasiraWorld Health Organization-Liberia, Monrovia, Liberia.
Tolbert NyenswahNational Public Health Institute of Liberia, Monrovia, Liberia.
Xin WangDivision of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
LeAnne M FoxDivision of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: lfox@cdc.gov.
Liberian Meningococcal Disease Outbreak Response Team

Funding

Intramural CDC HHS CC999999World Health Organization 001
6 · The paper itself

Abstract

backgroundOn April 25, 2017, a cluster of unexplained illnesses and deaths associated with a funeral was reported in Sinoe County, Liberia. Molecular testing identified Neisseria meningitidis serogroup C (NmC) in specimens from patients. We describe the epidemiological investigation of this cluster and metagenomic characterisation of the outbreak strain.

methodsWe collected epidemiological data from the field investigation and medical records review. Confirmed, probable, and suspected cases were defined on the basis of molecular testing and signs or symptoms of meningococcal disease. Metagenomic sequences from patient specimens were compared with 141 meningococcal isolate genomes to determine strain lineage.

findings28 meningococcal disease cases were identified, with dates of symptom onset from April 21 to April 30, 2017: 13 confirmed, three probable, and 12 suspected. 13 patients died. Six (21%) patients reported fever and 23 (82%) reported gastrointestinal symptoms. The attack rate for confirmed and probable cases among funeral attendees was 10%. Metagenomic sequences from six patient specimens were similar to a sequence type (ST) 10217 (clonal complex [CC] 10217) isolate genome from Niger, 2015. Multilocus sequencing identified five of seven alleles from one specimen that matched ST-9367, which is represented in the PubMLST database by one carriage isolate from Burkina Faso, in 2011, and belongs to CC10217.

interpretationThis outbreak featured high attack and case fatality rates. Clinical presentation was broadly consistent with previous meningococcal disease outbreaks, but predominance of gastrointestinal symptoms was unusual compared with previous African meningitis epidemics. The outbreak strain was genetically similar to NmC CC10217, which caused meningococcal disease outbreaks in Niger and Nigeria. CC10217 had previously been identified only in the African meningitis belt.

fundingUS Global Health Security.

Indexed as

Disease OutbreaksAdolescentAdultAgedAged, 80 and overChildContact TracingFemaleGenotypeHumansLiberiaMaleMeningitis, MeningococcalMetagenomicsMiddle AgedMolecular Epidemiology

Identifiers

PMID30337259
PMCPMC6545567

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.